Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction-Reference-Cited by-同舟云学术

Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction

Published:2021-03-07 Issue:3 Volume:8 Page:2058-2069
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Moon Mi‐Gil¹,Hwang In‐Chang¹²^ORCID,Choi Wonsuk¹²,Cho Goo‐Yeong¹²,Yoon Yeonyee E.¹²,Park Jun‐Bean²³,Lee Seung‐Pyo²³,Kim Hyung‐Kwan²³,Kim Yong‐Jin²³

Affiliation:

1. Department of Cardiology, Cardiovascular Center Seoul National University Bundang Hospital Seongnam South Korea

2. Department of Internal Medicine Seoul National University College of Medicine Seoul South Korea

3. Cardiovascular Center and Department of Internal Medicine Seoul National University Hospital Seoul South Korea

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13285

Reference28 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis

3. Association of change in N‐terminal pro‐B‐type natriuretic peptide following initiation of sacubitril‐valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction;Januzzi JL;JAMA,2019

4. Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis

5. Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization study;European Heart Journal;2024-06-12

2. State of the art on angiotensin-neprilysin inhibitors;Minerva Cardiology and Angiology;2024-06

3. On-Treatment Blood Pressure and Dose-Dependent Effects of ARNI in Heart Failure with Reduced Ejection Fraction: Insights from a Multicenter Registry;2024-04-17

4. Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients;International Journal of Cardiology;2024-02

5. Cardiac reverse remodelling by imaging parameters with recent changes to guideline medical therapy in heart failure;ESC Heart Failure;2023-10-23